Ijinkai Takeda General Hospital
In research, Ijinkai Takeda General Hospital stands highest in Medicine (#9,334 of 10,443 worldwide) and Health Sciences (#11,068 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery — Surgery is 9.0× its share of world research.
- World rank, 2022–2025
- #26,062 of 28,054 · #33,072 all time
- Rank in Japan
- #938 of 1,070
- Research works
- 647 ▲ 7% vs 2013–17
- Citations
- 5.5k 8.5 per fractional work
- Top-10% rate
- 6.4% record average 16.5%
- Open access
- 53% world 28%
What is Ijinkai Takeda General Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,334 of 10,443 | 6.5% | 101 | #10786 | |
| Health SciencesDomain | #11,068 of 11,982 | 6.4% | 104 | #13855 |
Each strip is that field’s whole ranked pool, with the notch where Ijinkai Takeda General Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ijinkai Takeda General Hospital specialise in?
Where its research is concentrated relative to its size: Surgery takes 9.0× the share of its output that it takes of world research.
- SurgerySubfield · 24.4 works9.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.5×. Every wedge is a field page.
- Medicine 4.5×
- Neuroscience 1.1×
- Nursing 0.9×
- Dentistry 0.9×
- Immunology and Microbiology 0.7×
- Health Professions 0.7×
- Biochemistry, Genetics and Molecular Biology 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Psychology 0.2×
- Economics, Econometrics and Finance 0.2×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Social Sciences 0.0×
- Materials Science 0.0×
- Mathematics 0.0×
Who are the top researchers at Ijinkai Takeda General Hospital?
Ranked on the composite score, Makoto Yamada, Kunio Yokoyama and Takashi Okada lead among researchers whose main affiliation is Ijinkai Takeda General Hospital.
- 1 Makoto Yamada Japan · #530,387 worldwide 26 citations · 29 works
- 2 Kunio Yokoyama Japan · #639,464 worldwide 27 citations · 24 works
- 3 Takashi Okada Japan · #699,408 worldwide 22 citations · 31 works
- 4 Kazuo Yasuhara Japan · #747,770 worldwide 21 citations · 25 works
- 5 Masahiro Kawanishi Japan · #1,116,932 worldwide 16 citations · 40 works
- 6 Akira Sugie Japan · #1,156,236 worldwide 11 citations · 16 works
- 7 Toru Kanno Japan · #1,174,659 worldwide 38 citations · 63 works
- 8 Katsuhiro Ito Japan · #1,202,044 worldwide 8 citations · 39 works
- 9 Yoshihito Higashi Japan · #1,269,894 worldwide 8 citations · 23 works
- 10 Naokado Ikeda Japan · #1,474,672 worldwide 6 citations · 17 works
Which keywords describe research at Ijinkai Takeda General Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Management, Guidelines, Treatment, Epidemiology, Chemotherapy, Catheter Ablation, Surgical Management and Genetic Mutations.
- Spinal Surgery
- Endovascular Treatment
- Pedicle Screw Fixation
- Arrhythmias
- Magnetic Resonance Imaging
- Atrial Fibrillation
- Robotic Surgery
- Degenerative Disc Disease
- Anticoagulant Therapy
- Prevalence
- Biomechanics
- Medical Therapy
- Stroke Prevention
- Prognostic Factors
- Immunotherapy
- Catheter Ablation
- Metabolic Syndrome
- Inflammation
- Guidelines
- Treatment
- Epidemiology
- Management
- Chemotherapy
- Risk Factors
- Diagnosis
- Genetic Mutations
- Surgical Management
- Surgery
- Molecular Characterization
- Spinal Fusion
- Complications
- Prevention
- Calcium Oxalate
- Urolithiasis
- Treatment Guidelines
- Low Back Pain
- Risk Stratification
- Neoadjuvant Therapy
- Vertebroplasty
- Survival Analysis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology12▲ 2.6×39 topics
- Treatment8▲ 5.8×19 topics
- Management8▲ 8.8×15 topics
- Guidelines7▲ 14×10 topics
- Chemotherapy6▲ 8.0×15 topics
- Inflammation6▲ 2.4×29 topics
- Risk Factors6▲ 4.5×13 topics
- Metabolic Syndrome5▲ 5.5×9 topics
- Diagnosis5▲ 4.7×18 topics
- Catheter Ablation5▲ 35×2 topics
- Genetic Mutations5▲ 9.3×10 topics
- Immunotherapy5▲ 5.7×12 topics
- Surgical Management5▲ 9.8×12 topics
- Prognostic Factors4▲ 8.5×11 topics
- Surgery4▲ 10.0×8 topics
- Stroke Prevention4▲ 28×2 topics
- Molecular Characterization4▲ 18×4 topics
- Medical Therapy4▲ 76×2 topics
- Spinal Fusion4▲ 32×2 topics
- Biomechanics4▲ 9.9×5 topics
- Complications4▲ 6.0×9 topics
- Prevalence4▲ 7.4×4 topics
- Prevention4▲ 7.1×8 topics
- Anticoagulant Therapy3▲ 24×3 topics
- Calcium Oxalate3▲ 119×1 topic
- Degenerative Disc Disease3▲ 30×2 topics
- Urolithiasis3▲ 119×1 topic
- Robotic Surgery3▲ 18×4 topics
- Treatment Guidelines3▲ 12×4 topics
- Atrial Fibrillation3▲ 26×1 topic
- Low Back Pain3▲ 14×3 topics
- Magnetic Resonance Imaging3▲ 9.8×4 topics
- Risk Stratification3▲ 35×1 topic
- Arrhythmias3▲ 25×2 topics
- Neoadjuvant Therapy3▲ 10×5 topics
- Pedicle Screw Fixation3▲ 60×1 topic
- Vertebroplasty3▲ 60×1 topic
- Endovascular Treatment2▲ 36×2 topics
- Survival Analysis2▲ 7.6×5 topics
- Spinal Surgery2▲ 25×2 topics
Which research topics does Ijinkai Takeda General Hospital publish most on?
By volume in 2022–2025: Kidney Stones and Urolithiasis Treatments, Atrial Fibrillation Management and Outcomes, Spinal Fractures and Fixation Techniques and Spine and Intervertebral Disc Pathology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 3 works
- 2 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 3 works
- 3 Spinal Fractures and Fixation Techniques Surgery 3 works
- 4 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 2 works
- 5 Cardiac Arrhythmias and Treatments Cardiology and Cardiovascular Medicine 2 works
- 6 Pediatric Urology and Nephrology Studies Pediatrics, Perinatology and Child Health 2 works
- 7 Bladder and Urothelial Cancer Treatments Surgery 2 works
- 8 Urinary Tract Infections Management Epidemiology 2 works
- 9 Ureteral procedures and complications Obstetrics and Gynecology 2 works
- 10 Scoliosis diagnosis and treatment Surgery 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ijinkai Takeda General Hospital's research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kyoto
- Kyoto University
- Ritsumeikan University
- Kyoto Prefectural University of Medicine
- Kyoto Institute of Technology
- Doshisha University
- Kyoto Pharmaceutical University
- Ryukoku University
- Ōtani University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.